TrialJectory seals $2.7 mln seed

New York City-based TrialJectory, an AI-powered technology platform that uses self-reported clinical data to match cancer patients with clinical trials, has secured $2.7 million in seed financing.

New York City-based TrialJectory, an AI-powered technology platform that uses self-reported clinical data to match cancer patients with clinical trials, has secured $2.7 million in seed financing. Contour Venture Partners led the round.

Source: Press Release